跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
思而赞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Imiglucerase for Injection
Approved
生物制品
Imiglucerase for Injection
Sanofi B.V.
🇨🇳 National Medical Products Administration
Approval Date
Oct 26, 2023
Approval ID
8ajBfGOSy1M
Company
Sanofi B.V.
Type
生物制品
Approval Details
Approval Id
8ajBfGOSy1M
Approval Number
国药准字SJ20140067
Generic Name
注射用伊米苷酶
Generic Name En
Imiglucerase for Injection
Trade Name
思而赞
Drug Type
生物制品
Dosage Form
注射剂
Strength
400单位/瓶
Reg Date
2023-10-26
Expired Date
2028-10-25
Company Name
Sanofi B.V.
Production Company Name
Genzyme Ireland Ltd.
Company Detail Path
/organization/sanofi-b-v
Production Company Detail Path
/organization/genzyme-ireland-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 26, 2023
Approval ID
8ajBfGOSy1M
Type
生物制品
Back to NMPA Approvals